RecruitingACTRN12618001959268

BRAIN: Development of a detailed database for collection of clinical data in patients with brain cancer

BRAIN: Development of a detailed database for collection of clinical data in patients with brain cancer.


Sponsor

The Walter and Eliza Hall Institute of Medical Research

Enrollment

10,000 participants

Start Date

Feb 18, 2021

Study Type

Observational

Conditions

Summary

The aim of this study is to establish a comprehensive clinical registry for patients with brain tumours in Australia. Who is it for? You may be eligible to join this study if you are aged 18 years or above and have been diagnosed with a brain tumour. Study details Participants in this study will continue to receive routine clinical care, which will not be impacted by involvement in this study. All enrolled patients will have clinical data collected for up to 5 years. Data captured will include presentation and the disease course of brain tumours, surgical interventions, prescription of system therapies, and information regarding multi-disciplinary management and outcomes of this disease in the routine clinical practice setting. This registry will help to describe the current practice patterns and identify any deficiencies or abnormalities. By doing so, we can ensure that Australian brain tumour patients receive the best care possible.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study is establishing a detailed national clinical registry for Australians diagnosed with brain tumours, including gliomas, meningiomas, brain metastases, and other rare brain tumours. Rather than testing a new treatment, this is a data collection project — a registry — that will carefully record each patient's diagnosis, surgical procedures, treatments received, and health outcomes over up to five years. Having this kind of comprehensive, real-world data is crucial for understanding how brain tumours are managed across Australia, identifying any gaps in care, and informing future research. It will also help track whether patients are receiving care consistent with current best-practice guidelines. You may be eligible if you are 18 or older and have a histologically confirmed brain tumour (confirmed by examining a tissue sample). People with cerebral lymphoma are not included in this registry.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

The follow-up period is 5 years. No additional tests are required, all data will be collected from the medical record of patients with histologically confirmed brain tumours. Data captured will includ

The follow-up period is 5 years. No additional tests are required, all data will be collected from the medical record of patients with histologically confirmed brain tumours. Data captured will include presentation and disease characteristics, surgical interventions, prescription of system therapies, and information regarding multi-disciplinary management and outcomes of this disease in the routine clinical practice setting.


Locations(13)

Royal Melbourne Hospital - City campus - Parkville

VIC, Australia

Peter MacCallum Cancer Centre - Melbourne

VIC, Australia

St Vincent's Hospital (Melbourne) Ltd - Fitzroy

VIC, Australia

St Vincent's Private Hospital - Fitzroy

VIC, Australia

Southwest Health Care - Warrnambool - Warrnambool

VIC, Australia

Royal Hobart Hospital - Hobart

VIC, Australia

Barwon Health - Geelong Hospital campus - Geelong

VIC, Australia

Bendigo Health Care Group - Bendigo Hospital - Bendigo

VIC, Australia

Austin Health - Austin Hospital - Heidelberg

VIC, Australia

The Alfred - Melbourne

VIC, Australia

Cabrini Hospital - Malvern - Malvern

VIC, Australia

Monash Medical Centre - Clayton campus - Clayton

VIC, Australia

Epworth Richmond - Richmond

VIC, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12618001959268


Related Trials